Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1PXY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,197
Award facts
- Contract value 100% obligated
- $14,196.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,196.97 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes. This competitively awarded, firm fixed-price delivery order was executed on December 29, 2025, with an ultimate completion date of December 30, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9 million and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a wide range of pharmaceutical products and medical supplies through competitive procurement, with delivery orders typically structured on firm fixed-price terms. Dupixent is a specialty medication used in the treatment of various inflammatory conditions, and this delivery order fulfills a specific medical supply requirement within the broader DLA pharmaceutical prime vendor program supporting military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F1PXY?
SPE2DR26F1PXY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26F1PXY worth?
The government has obligated $14,197 on SPE2DR26F1PXY.
Is contract SPE2DR26F1PXY an order under another contract?
Yes. SPE2DR26F1PXY is a delivery order under SPE2DR25D3108, an indefinite delivery contract.
Was contract SPE2DR26F1PXY competed?
The extent of competition for SPE2DR26F1PXY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award